Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastatic patterns in adenocarcinoma.

Kenneth R Hess1, Gauri R Varadhachary, Sarah H Taylor

  • 1Department of Biostatistics and Applied Mathematics, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA. khess@mdanderson.org

Cancer
|March 7, 2006
PubMed
Summary

This study analyzed cancer metastasis patterns in over 4000 patients, identifying dominant metastatic sites for various primary tumors. Predictive algorithms achieved 64% accuracy in determining primary tumor locations from metastatic patterns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editor's Note: Deciphering the Mechanisms of Tumorigenesis in Human Pancreatic Ductal Epithelial Cells.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2024
Same author

A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.

Gynecologic oncology·2024
Same author

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma.

Journal for immunotherapy of cancer·2023
Same author

A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2023
Same author

Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.

Journal of the National Cancer Institute·2023

Area of Science:

  • Oncology
  • Medical Informatics

Background:

  • Traditional understanding of cancer metastasis relies on limited anecdotal evidence.
  • Distant-stage adenocarcinoma presents unique and varied metastatic patterns.

Purpose of the Study:

  • To systematically evaluate metastatic patterns in distant-stage adenocarcinoma.
  • To develop predictive algorithms for primary tumor identification based on metastasis patterns.

Main Methods:

  • Analysis of tumor registry data from 4399 patients (1994-1996) with 11 primary and 15 metastatic sites.
  • Cross-tabulation of primary and metastatic sites to identify patterns.
  • Development of multinomial logistic regression algorithms for prediction.

Main Results:

Related Experiment Videos

  • Identified dominant metastatic sites for specific primary tumors (e.g., ovary to abdominal cavity, prostate to bone, pancreas to liver).
  • Liver was the dominant site for gastrointestinal (GI) primaries; bone/lung for non-GI primaries.
  • Algorithms achieved 64% accuracy in predicting primary tumor location from metastatic patterns.

    • Conclusions:

    • Established distinct metastatic patterns for various adenocarcinocarcinomas.
    • Developed a validated algorithm for predicting primary tumor origin from metastasis data.
    • Demonstrated significant improvement over random classification in predicting primary tumor sites.